Guggenheim analyst Seamus Fernandez reiterates Apogee Therapeutics (NASDAQ:APGE) from Buy to Buy.
- Headlines
- Guggenheim Reiterates Buy on Apogee Therapeuticsto Buy
Guggenheim Reiterates Buy on Apogee Therapeuticsto Buy
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
15:10
The design of the Firefly has sparked controversy; Li Bin responded that the Europe team and partners really like it, and many users in China have not yet seen the actual vehicle.
NIO Inc. USD OV+2.23%
15:09
CITIC SEC: Insurance stocks are expected to continue to perform in a beta market, suggesting a balanced allocation of major insurance stocks.
CITIC+0.83%
15:08
CITIC SEC: The inventory preparation for New Year's Day and Spring Festival has begun, and the sales of Baijiu are expected to be stable.
CITIC+0.83%